Zhang X, Cao Y, Wei J, Zhai W, et al. Efficacy and Safety of the Third-Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed D Am J Hematol 2025 Aug 6. doi: 10.1002/ajh.70026.
PMID: 40767498